Royal Bank of Canada’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-875
Closed -$1K 7793
2021
Q1
$1K Buy
+875
New +$1.77K ﹤0.01% 7349

Other funds holding APGNW

Royal Bank of Canada's APGNW Position: Q2 2021 in Review

Royal Bank of Canada sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q2 2021, closing a stake of 875 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in APGNW in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 11 funds tracked by Wall St. Rank hold APGNW as of Q2 2021.

  • Royal Bank of Canada reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 875 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q2 2021, an estimated $1K.
  • Royal Bank of Canada first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 1 quarter.
  • Royal Bank of Canada's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $1K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q2 2021.

Based on Royal Bank of Canada's 13F filing for Q2 2021, filed 16 Aug 2021.